Press Releases Year None20212020201920182017 January 5, 2021 SpringWorks Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference PDF Version December 15, 2020 SpringWorks Therapeutics Announces Executive Leadership Promotions PDF Version November 24, 2020 SpringWorks Therapeutics to Participate in the Evercore ISI HealthCONx Conference PDF Version November 12, 2020 SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights PDF Version October 26, 2020 Jazz Pharmaceuticals Acquires SpringWorks Therapeutics’ FAAH Inhibitor Program PDF Version October 13, 2020 SpringWorks Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares PDF Version October 7, 2020 SpringWorks Therapeutics Announces Pricing of Public Offering of Common Stock PDF Version October 6, 2020 SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock PDF Version October 5, 2020 SpringWorks Therapeutics Announces Clinical Collaboration with Pfizer Inc. to Evaluate Nirogacestat in Combination with PF‐06863135 in Patients with Relapsed or Refractory Multiple Myeloma PDF Version September 22, 2020 SpringWorks Therapeutics to Participate in H.C. Wainwright Precision Oncology Investor Conference PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Next page next › Last page last »
January 5, 2021 SpringWorks Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference PDF Version
November 24, 2020 SpringWorks Therapeutics to Participate in the Evercore ISI HealthCONx Conference PDF Version
November 12, 2020 SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights PDF Version
October 26, 2020 Jazz Pharmaceuticals Acquires SpringWorks Therapeutics’ FAAH Inhibitor Program PDF Version
October 13, 2020 SpringWorks Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares PDF Version
October 7, 2020 SpringWorks Therapeutics Announces Pricing of Public Offering of Common Stock PDF Version
October 6, 2020 SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock PDF Version
October 5, 2020 SpringWorks Therapeutics Announces Clinical Collaboration with Pfizer Inc. to Evaluate Nirogacestat in Combination with PF‐06863135 in Patients with Relapsed or Refractory Multiple Myeloma PDF Version
September 22, 2020 SpringWorks Therapeutics to Participate in H.C. Wainwright Precision Oncology Investor Conference PDF Version
